Documentation scienceplus.abes.fr version Bêta

À propos de : BET 4: Management of adult patients with icatibant in hereditary angioedema        

AttributsValeurs
type
Is Part Of
Subject
Title
  • BET 4: Management of adult patients with icatibant in hereditary angioedema
has manifestation of work
Abstract
  • A short-cut review was carried out to establish whether icatibant is effective in the treatment of hereditary angioedema. A total of 168 papers were found using the reported search, of which one represented the best evidence to answer the clinical question. The author, date and country of publication, patient group studied, study type, relevant outcomes, results, and study weaknesses of this best paper are tabulated. The clinical bottom line is there is promising evidence for the use of the bradykinin receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema.
article type
publisher identifier
  • emermed-2011-200396-4
is part of this journal



Alternative Linked Data Documents: ODE     Content Formats:       RDF       ODATA       Microdata